These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8180601)

  • 21. Responses of hairy cell leukemia cells to a recombinant alpha-2 interferon in vitro and in vivo: correlation between formation of tubuloreticular structures and clinical parameters.
    Hiraoka A; Golomb HM
    J Biol Response Mod; 1986 Jun; 5(3):270-81. PubMed ID: 3723140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrastructural, immunologic and clinical follow-up of five patients with HCL treated with interferon (IFN) for more than three years.
    Mantovani G; Astara G; Curreli L; Lai P; Turnu E; Locci F; Lantini MS; Cossu M; Riva A; Del Giacco GS
    Haematologica; 1992; 77(4):326-35. PubMed ID: 1427443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-alpha in vivo enhances tumor necrosis factor receptor levels on hairy cells.
    Billard C; Sigaux F; Wietzerbin J
    J Immunol; 1990 Sep; 145(6):1713-8. PubMed ID: 2167909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanism of action of interferon-alpha (IFN-alpha) in hairy-cell leukaemia; Hu-IFN-alpha 2 receptor expression by hairy cells and other normal and leukaemic cell types.
    Dadmarz R; Evans T; Secher D; Marshall N; Cawley J
    Leuk Res; 1986; 10(11):1279-85. PubMed ID: 2948077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of hairy cells to IFN-alpha involves induction of apoptosis through autocrine TNF-alpha and protection by adhesion.
    Baker PK; Pettitt AR; Slupsky JR; Chen HJ; Glenn MA; Zuzel M; Cawley JC
    Blood; 2002 Jul; 100(2):647-53. PubMed ID: 12091360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
    Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
    J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. alpha-Interferon inhibits spontaneous and induced DNA synthesis in hairy cell leukemia.
    Hassan IB; Gronowitz JS; Carlsson M; Sundström C
    Leuk Lymphoma; 1992 May; 7(1-2):69-77. PubMed ID: 1472934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficient IFN alpha production in hairy cell leukemia.
    Porzsolt F; Janik R; Heil G; Brudler O; Raghavachar A; Scholz S; Papendick U; Heimpel H
    Blut; 1986 Mar; 52(3):185-90. PubMed ID: 3006840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The therapeutic effect of interferon-alpha exemplified by hairy cell leukemia].
    Schwarzmeier JD
    Wien Med Wochenschr; 1993; 143(16-17):412-5. PubMed ID: 8273363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hairy-cell leukemia and alpha-interferon treatment: long-term responders.
    Zinzani PL; Lauria F; Salvucci M; Rondelli D; Raspadori D; Bendandi M; Magagnoli M; Tura S
    Haematologica; 1997; 82(2):152-5. PubMed ID: 9175317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression and localization of the cytoskeleton-binding pp52 (LSP1) protein in hairy cell leukemia.
    Miyoshi EK; Stewart PL; Kincade PW; Lee MB; Thompson AA; Wall R
    Leuk Res; 2001 Jan; 25(1):57-67. PubMed ID: 11137562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-alpha-induced changes in surface antigens in a hairy-cell leukemia (JOK-1), and a Burkitt's lymphoma cell line (Daudi) during in vitro culture.
    Nielsen B; Madsen PS; Jensen AW; Hokland P; Hokland M
    Eur J Haematol; 1992 Mar; 48(3):146-51. PubMed ID: 1559570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of BCL-2 confers interferon-alpha sensitivity to B-cell lymphomas.
    Karauzum SB; Yasar D; Dirice E; Imir N; Luleci G; Ozes ON
    Growth Factors; 2007 Apr; 25(2):94-100. PubMed ID: 17852408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
    Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
    Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autocrine and paracrine regulation of neoplastic cell growth in hairy cell leukemia.
    Schmid M; Porzsolt F
    Leuk Lymphoma; 1995 May; 17(5-6):401-10. PubMed ID: 7549830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of tumor necrosis factor in response to interferon-alpha in hairy cell leukemia.
    Billard C; Lasfar A
    Leukemia; 1993 Feb; 7(2):331-2. PubMed ID: 8426486
    [No Abstract]   [Full Text] [Related]  

  • 38. Production of tumor necrosis factor-alpha by normal and malignant B lymphocytes in response to interferon-alpha, interferon-gamma and interleukin-4.
    Jansen JH; Wientjens GJ; Willemze R; Kluin-Nelemans JC
    Leukemia; 1992 Feb; 6(2):116-9. PubMed ID: 1552742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatment options in hairy cell leukemia and hairy cell leukemia variant.
    Robak T
    Cancer Treat Rev; 2006 Aug; 32(5):365-76. PubMed ID: 16781083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hairy cell leukemia: an ultrastructural study of hairy cells before and after interferon therapy.
    Morroni M; Cinti S
    Tumori; 1995; 81(4):249-55. PubMed ID: 8540121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.